Research Update CHF 03300 MY1: Probiotic Prevention of GI Hyperpermeability and Metabolome Disturbances in Dogs with Multicentric Lymphoma Undergoing Multi-drug Chemotherapy

Posted on by Janet Boyd in Research Update

The study has been open for enrollment since Jan 1, 2025. Thus far, no dogs have been enrolled, so there is no clinical or objective data to report.

CHF 03300 MY1 Probiotic Prevention of GI Hyperpermeability and Metabolome Disturbances in Dogs with Multicentric Lymphoma Undergoing Multi-drug Chemotherapy